Khrom Capital Management’s Medline Inc MDLN Stock Holding History

Khrom Capital Management’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.3M	Buy	+703,137	New	+$31M	2.86%	13

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Khrom Capital Management's MDLN Position: Q1 2026 in Review

Khrom Capital Management opened a new position in Medline Inc (MDLN) in Q1 2026: 703,137 shares worth $31.3M. The stake represents 2.86% of the portfolio and ranks #13 among its holdings.

314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Khrom Capital Management held 703,137 shares of Medline Inc worth $31.3M as of Q1 2026.
Medline Inc was a new Khrom Capital Management position in Q1 2026.
Medline Inc made up 2.86% of Khrom Capital Management's portfolio in Q1 2026, its #13 holding.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Khrom Capital Management's 13F filing for Q1 2026, filed 15 May 2026.